Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1992 May;76(5):257–258. doi: 10.1136/bjo.76.5.257

Aspirin and cataract.

H Cheng
PMCID: PMC504249  PMID: 1390503

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cotlier E., Sharma Y. R. Aspirin and senile cataracts in rheumatoid arthritis. Lancet. 1981 Feb 7;1(8215):338–339. doi: 10.1016/s0140-6736(81)91965-6. [DOI] [PubMed] [Google Scholar]
  2. Crompton M., Rixon K. C., Harding J. J. Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: a possible mechanism by which aspirin could prevent cataract. Exp Eye Res. 1985 Feb;40(2):297–311. doi: 10.1016/0014-4835(85)90014-4. [DOI] [PubMed] [Google Scholar]
  3. Harding J. J. Aspirin and cataract. Arch Ophthalmol. 1991 Oct;109(10):1344–1345. doi: 10.1001/archopht.1991.01080100024010. [DOI] [PubMed] [Google Scholar]
  4. Klein B. E., Klein R., Moss S. E. Is aspirin use associated with lower rates of cataracts in diabetic individuals? Diabetes Care. 1987 Jul-Aug;10(4):495–499. doi: 10.2337/diacare.10.4.495. [DOI] [PubMed] [Google Scholar]
  5. Kupfer C. Bowman lecture. The conquest of cataract: a global challenge. Trans Ophthalmol Soc U K. 1985;104(Pt 1):1–10. [PubMed] [Google Scholar]
  6. Mohan M., Sperduto R. D., Angra S. K., Milton R. C., Mathur R. L., Underwood B. A., Jaffery N., Pandya C. B., Chhabra V. K., Vajpayee R. B. India-US case-control study of age-related cataracts. India-US Case-Control Study Group. Arch Ophthalmol. 1989 May;107(5):670–676. doi: 10.1001/archopht.1989.01070010688028. [DOI] [PubMed] [Google Scholar]
  7. Peto R., Gray R., Collins R., Wheatley K., Hennekens C., Jamrozik K., Warlow C., Hafner B., Thompson E., Norton S. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988 Jan 30;296(6618):313–316. doi: 10.1136/bmj.296.6618.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Seddon J. M., Christen W. G., Manson J. E., Buring J. E., Sperduto R. D., Hennekens C. H. Low-dose aspirin and risks of cataract in a randomized trial of US physicians. Arch Ophthalmol. 1991 Feb;109(2):252–255. doi: 10.1001/archopht.1991.01080020098052. [DOI] [PubMed] [Google Scholar]
  9. Sharma Y. R., Vajpayee R. B., Bhatnagar R., Mohan M., Azad R. V., Kumar M., Nath R. Systemic aspirin and systemic vitamin E in senile cataracts: cataract V. Indian J Ophthalmol. 1989 Jul-Sep;37(3):134–141. [PubMed] [Google Scholar]
  10. Swamy M. S., Abraham E. C. Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo. Invest Ophthalmol Vis Sci. 1989 Jun;30(6):1120–1126. [PubMed] [Google Scholar]
  11. West S. K., Muñoz B. E., Newland H. S., Emmett E. A., Taylor H. R. Lack of evidence for aspirin use and prevention of cataracts. Arch Ophthalmol. 1987 Sep;105(9):1229–1231. doi: 10.1001/archopht.1987.01060090087034. [DOI] [PubMed] [Google Scholar]
  12. van Heyningen R., Harding J. J. Do aspirin-like analgesics protect against cataract? A case-control study. Lancet. 1986 May 17;1(8490):1111–1113. doi: 10.1016/s0140-6736(86)91834-9. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES